ArticleClinical case reports2021

Which immunosuppressive drug is preferred in the treatment of toxic epidermal necrolysis during COVID-19 outbreak?

Saeedeh Farajzadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.